Featured Research

from universities, journals, and other organizations

Physical activity may reduce risk of esophageal cancer

Date:
October 14, 2013
Source:
American College of Gastroenterology (ACG)
Summary:
Physical activity is associated with a reduced risk of esophageal cancer, particularly esophageal adenocarcinoma, according to a new meta-analysis of published observational studies.

Physical activity is associated with a reduced risk of esophageal cancer, particularly esophageal adenocarcinoma, according to a new meta-analysis of published observational studies presented by Mayo Clinic researcher Siddharth Singh, M.D., at the American College of Gastroenterology's 78th Annual Scientific Meeting in San Diego, CA.

In a meta-analysis of four studies, Dr. Singh and his colleagues observed a 32 percent lower risk of esophageal adenocarcinoma, which can arise from Barrett's esophagus, in people who were physically active. The meta-analysis also showed the overall risk of esophageal cancer was 19 percent lower among the most physically active people, compared with the least physically active.

"Obesity has been associated with increased risk of esophageal cancer through high levels of insulin, as well as chronic inflammation. By decreasing visceral fat, lowering the level of carcinogenic adipokines, improving insulin sensitivity, and decreasing chronic inflammation, physical activity can potentially decrease risk of esophageal cancer," said Dr. Singh.

Esophageal cancer is the sixth most common cancer in men worldwide, and has a dismal five-year survival rate of approximately 15 percent, with most patients dying within the first year of diagnosis. There are two types of esophageal cancer: esophageal squamous cell, which begins in cells lining the esophagus, and adenocarcinoma, which begins in cells that make and release mucus and other fluids. Dr. Singh and colleagues note that although, "the incidence of esophageal squamous cell cancer is declining worldwide, the incidence of esophageal adenocarcinoma has been rapidly rising. This increase may be partly attributable to the obesity epidemic."

Current evidence for this link has been limited to observational studies. According to Dr. Singh it is too early to conclude that exercise directly decreases esophageal cancer risk. He proposes that physically active people may be more likely to take preventive health measures, as compared to patients who are not physically active. Thus, he says, it is possible that other healthy lifestyle behaviors aside from physical activity contribute to a lower cancer risk.

There are ongoing randomized controlled trials assessing the effect of exercise on esophageal cancer risk in patients with Barrett's esophagus.


Story Source:

The above story is based on materials provided by American College of Gastroenterology (ACG). Note: Materials may be edited for content and length.


Cite This Page:

American College of Gastroenterology (ACG). "Physical activity may reduce risk of esophageal cancer." ScienceDaily. ScienceDaily, 14 October 2013. <www.sciencedaily.com/releases/2013/10/131014093533.htm>.
American College of Gastroenterology (ACG). (2013, October 14). Physical activity may reduce risk of esophageal cancer. ScienceDaily. Retrieved July 21, 2014 from www.sciencedaily.com/releases/2013/10/131014093533.htm
American College of Gastroenterology (ACG). "Physical activity may reduce risk of esophageal cancer." ScienceDaily. www.sciencedaily.com/releases/2013/10/131014093533.htm (accessed July 21, 2014).

Share This




More Health & Medicine News

Monday, July 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins